Register here to subscribe to the print and digital copies of PRIME Journal and get unrestricted access to all news, analysis and peer-reviewed content on our website.

Register or Find out more


PRIME Journal

Search Account

Already Registered?

Forgotten Password?

Register for free

Register for FREE and get unrestricted access to all news, analysis and peer-reviewed content, and create your own tailored alerts.


Non-Surgical Rejuvenation of the Periorbital Area

Patrick_Treacy_©Billy_Rogers By Patrick Treacy / Posted in on May 18, 2016

Patrick Treacy discusses the options available for the rejuvenation of the periorbital area, including chemical peels, fillers, and microfocused ultrasound….

Patrick Treacy discusses the options available for the rejuvenation of the periorbital area, including chemical peels, fillers, and microfocused ultrasound.

The demand for non-invasive and minimally invasive skin-tightening procedures is rising within the aesthetic world as patients seek safe and effective alternatives to aesthetic surgical procedures of the face, neck, and body. The face, and more specifically the eyes, is the area for which most patients seek cosmetic rejuvenation as it is very important in contact between humans; providing a window to the rest of society regarding a patient’s level of health, tiredness, emotional status as well as interest in others. The periorbital area, consisting of the eyelids and surrounding areas, including the eyebrows, bony eye socket and rims, cheeks, and forehead is also the first area to show signs of ageing.  Periorbital ageing involves changes that are multidimensional and multifactorial. Surgical procedures address some aspects of periorbital ageing but leave many elements untreated. The eyes and eyelids are very complex and delicate areas, and as such need to be approached and treated with care (Figure 1). Recent literature has shown that changes occurring in the bony structure surrounding the eye causes a substantial impact upon the ageing process especially with respect to volumetric changes1.

Screen Shot 2016-05-18 at 12.59.05A variety of differing aesthetic treatments are available for non-surgical periorbital rejuvenation but one procedure or technique alone is usually insufficient. Techniques include botulinum injections, chemical peels, dermal fillers, plasma rich platelets, micro-needling, micro-focused high intensity ultrasound, and radiofrequency as well as non-ablative and ablative lasers2. Although these less invasive treatments will not replace surgery, a growing patient population is seeking results through low-risk procedures with associated minimal downtime. Essentially the science in non-surgical rejuvenation is built around concepts associated with wound healing and collagen generation. Each of these devices has their own relative benefits as well as their own risks. Periorbital rejuvenation techniques continue to improve as new technologies become available and their ability to administer the injury deep in the underlying tissue results in no visible signs of trauma on the outside and plumper smoother skin. The technology continually changes due to an increased ability to safely deliver energy to deeper tissue planes. A number of authors have described the benefit of combination techniques in treating the periorbital area3,4.


The periorbital anatomy is particularly well suited for botulinum toxin treatments and is the most frequent site to benefit from the cosmetic application of the toxin. Therapy is aimed at paralyzing specific muscles in order to reverse their effects on the overlying skin. Cosmetic benefits of botulinum toxin treatment include smoother, line-free skin, improved brow contour, and optimal post-surgical healing in certain circumstances. Botulinum toxin therapy is simple, effective, and forgiving, making it very popular among physicians and patients alike5. Dermatologic use of botulinum toxin has traditionally been applied to the treatment of glabellar furrows, forehead, and periorbital rhytides. Since periorbital rhytides result from both photoaging and contraction of the orbicularis oculi muscles, the treatment goal is muscle weakening, not paralysis6. Use of this treatment either prior to or after periorbital laser resurfacing augments the effects of the laser and helps maintain the improved appearance of wrinkles7.


Retinol is a cosmetic ingredient that is structurally similar to all-trans-retinoic acid, which has been shown to be effective in the treatment of photodamage. Since skin keratinocytes are reported to metabolize retinol to retinoic acid, investigators have hypothesized that retinol may also be helpful in improving skin photodamage8.

Chemical peels

Chemical peels are one of the most common dermatological procedures for skin rejuvenation. The process involves applying a caustic substance to the skin to produce a controlled partial thickness injury. Peels are categorized as superficial, medium, and deep. Superficial peels penetrate the epidermis down to the dermal-epidermal junction. These peels include Jessner’s solution, which is a combination of resorcinol, salicylic acid, and lactic acid in an alcohol solution. Glycolic acid at concentrations of 20% to 70% is a more popular agent used for superficial chemical peeling. Trichloroacetic acid (TCA) is a versatile peeling agent because the concentration may be adjusted in order to achieve the desired depth of peel. Concentrations of 15% to 35% TCA can be used for superficial peeling.

Medium-depth peels pertain to the use of agents or a combination of agents in order to produce an injury depth down to the upper reticular dermis. These peels are best used to treat actinic keratoses, dyschromia, and mild wrinkling9,10. Deep peels involve the use of chemoexfoliants that penetrate to the mid reticular dermis. Indications for their use include deep rhytides secondary to photo-damage and treatment of severe or extensive actinic keratoses. Deep chemical peeling entails longer healing times and increased potential for complications. Baker’s formula is the most commonly used deep chemical peel. It is composed of a mixture containing 3 ml 88% phenol USP, three drops croton oil, eight drops Septisol®, and 2 ml distilled water10.

Radiofrequency and infrared

Over the past decade, radiofrequency (RF) and infrared (IR) laser devices have been popularized owing to their ability to deliver controlled heat to the dermis, stimulate neocollagenesis, and effect modest tissue tightening with minimal recovery. These devices use radiofrequency (RF) energy and electrical energy to deliver a controlled thermal injury to heat skin.  RF entered the realm of periorbital skin rejuvenation in 2002 when the Food and Drug Administration (FDA) approved Thermage (Solta, Hayward, CA) for facial skin tightening. Since then, many different variants of RF devices including the monopolar Pellevé (Cynosure, Inc., Hicksville, NY) have been developed and approved by the FDA11,12. These devices deliver continuous monopolar RF energy, rather than pulsed heating, and repeatedly bring the skin to therapeutic temperatures until maximal contraction is obtained. Another effective bipolar RF device for the periorbital area is the Syneron Polaris, based on ELOS technology using conducted RF in combination with a high power diode laser. It has multiple applications including wrinkle and skin texture treatment (WR). The superposition of RF and light creates strong heating of the deep dermis with minimal risk of side-effects and the electrode design allows high energy delivery to a depth of 2.5 mm13,14. Infrared laser skin tightening is a minimally invasive way to tighten periorbital skin without surgery and help reverse some of the signs of ageing.

Screen Shot 2016-05-18 at 12.59.17

Screen Shot 2016-05-18 at 12.59.27Microfocused ultrasound

Microfocused ultrasound (MFU) has been recently developed to meet the public demand for periorbital skin lifting and tightening. This non-invasive device is called Ulthera® and the treatment is Ultherapy® (Ulthera, Inc., Mesa, AZ). It causes fractional thermal injury to a precisely set depth using ultrasound technology with minimal discomfort and transient erythema15. It can be focused on subcutaneous tissue, producing small (<1 mm) thermal coagulation points to a depth of up to 5 mm within the mid-to-deep reticular layer of the dermis and sub-dermis. The intervening papillary dermal and epidermal layers of skin remain unaffected. The application of heat at these discrete thermal coagulation points causes collagen fibres in the facial planes, such as the superficial musculoaponeurotic system and platysma, as well as the deep reticular dermis, to become denatured, contracting and stimulating de novo collagen14. The goal is to produce a deeper wound healing response at multiple levels with robust collagen remodelling and a more durable clinical response. By manipulating the ultrasound frequency, focal depth, power output, and duration of exposure, the temperature within the dermis can briefly be raised to 60 °C resulting in a discrete and reproducible zone of thermal coagulation16. Areas with the thinnest skin, such as the neck and periocular area, should be treated with superficial depth probes. The brow and temple should be treated with superficial and deeper probes, while cheeks and submental skin is best treated with the deepest 4 MHz/4.5 mm transducer followed by additional treatment with a superficial transducer17.

Filler augmentation

Materials were first used for facial filling purposes more than 100 years ago. In 1893, autologous fat transfer was described as a good substitute material for soft tissue augmentation18. The periorbital subunit is one of the first facial regions to show signs of ageing, primarily due to volume depletion of the soft tissue and bony resorption. In the early 1970s, Stanford University investigators presented a preliminary study on injectable collagen in the face. A decade or so later, collagen was approved by the FDA for medical use19. Many authors have published comprehensive treatment of the periorbital region with hyaluronic acid1,20. The tear trough or infraorbital hollow is a challenging area to treat, and only a few fillers are suitable for this delicate area. Tear trough deformity is a major concern in a lot of individuals seeking periorbital rejuvenation. A prominent tear trough deformity is characterised by a sunken appearance of the eye that results in the casting of a dark shadow over the lower eyelid, giving the patient a fatigued appearance despite adequate rest, and is refractory to attempts at cosmetic concealment. The tear trough deformity is a natural consequence of the anatomic attachments of the periorbital tissues. A variety of techniques have evolved to address this cosmetic issue21. Several forms of hyaluronic acid are available (benzyl esters of hyaluronic acid, HYAFF), with differing degradation profiles have been used periorbitally22–24. Calcium hydroxylapatite (CaHA; Radiesse®, Merz Pharmaceuticals GmbH, Frankfurt, Germany) an injectable filler material composed of synthetic calcium hydroxylapatite microspheres has been used to restore infraorbital malar volume with aesthetic effect in patients25–27.

Screen Shot 2016-05-18 at 12.59.42The aesthetically attractive lower eyelid should display a relatively smooth transition between the pre-septal and orbital portions of the orbicularis oculi muscle and continue into the upper malar region without a definable transition point28. Dark circles are often a result of tear trough deformity. However, the causes of dark circles can be multi-factorial. Changes in skin thickness, laxity, hyperpigmentation, and actinic changes also play a role. Thin skin or prominent subcutaneous venous pooling accentuates the periorbital darkening29. The term ‘tear trough deformity’ was coined by Flowers in his opinion, descent of the cheek, loss of facial volume, underdevelopment of the infraorbital malar complex and a muscular defect between the orbicularis muscle and angular head of the quadratus labii superioris muscle were all responsible for the formation of tear trough deformity30. Sadick et al., proposed a tear trough rating scale (TTRS). According to this TTRS, it was found that the tear trough was not simply an age-related deformity. It is often related to a forward projection of the bone of the upper cheek, and it may be more common in patients with either congenital or age-related maxillary hypoplasia31 (Figure 3).

A negative vector is when the cheek bone is relatively back to the projection of the eyeball or the front of the cornea. This means that the eye is forward while the cheekbone is back. It is important to balance everything. This is because the position of the lower eyelid is very dependent on multiple factors, such as the lateral canthal tendon, the position of the lower lid retractor, the tone of the skin and the orbicularis muscle. Sometimes one has to approach the tear trough in partnership with an oculoplastic surgeon to achieve the best result for your patient (Figure 4).

Autologous platelet rich plasma injections

Platelet-rich plasma (PRP) is a highly concentrated autologous solution of plasma prepared from a patient’s own blood. PRP contains platelets that are purported to release numerous growth factors that may be valuable in numerous dermatologic applications32. These injections were first used by Ferrari and Valbonesi in 1987 in open heart surgery and later in cosmetic use. Five major growth factors such as TGF, insulin-like growth factor (IGF), PDGF, EGF, and VEGF are known to be related to the wound-healing processes. These growth factors are released from platelets and the production of collagen of fibroblasts is stimulated by IGF, EGF, interleukin-1 (IL-1) and tumour necrosis factor (TNF)-α. In vivo studies report TGF-β to be the most stimulative growth factor. PRP has been used for dermal augmentation and Sclafani observed aesthetic improvements in less than 2 weeks and the results lasted for up to 3 months33,34.

Red light phototherapy

The benefits of red light phototheraScreen Shot 2016-05-18 at 12.59.58py on skin and hair has been known since 1967 after a Hungarian scientist noticed that shaved mice experienced better quality skin after exposure to 633 nm35. It is known that red light is absorbed by an intracellular enzyme, cytochrome c, responsible for stimulating fibroblasts by regulating gene activity and apoptosis36. Many different studies have been done to determine the efficacy of this wavelength in collagen production and skin rejuvenation37,38. To use red light in this specific area the author recommends using the specific eye covers supplied with these devices. GENO-LED (DTS MG., Korea,) is one such device used to deliver red light phototherapy.

Screen Shot 2016-05-18 at 13.00.21Collagen induction therapy

Collagen induction therapy (CIT) is an aesthetic medical procedure that involves repeatedly puncturing the skin with tiny, sterile needles. Typically, this is done with a specialized device called a microneedling device39,40. CIT appears to be a safe method for treating the periorbital region without destroying the epidermis. The procedure can be repeated safely and is also applicable in regions where laser treatments and deep peels are of limited use41,42. The author has used GENOSYS Eye roller (DTS MG., Korea,) with success as a CIT tool for the periorbital area.

Non-ablative and ablative lasers

Advances in laser technology in recent decades have increased the options for the treatment of dermatologic conditions of the eye and eyelid. The recent advent of fractionated laser technology has resulted in dramatically decreased healing times for periocular skin resurfacing and fewer adverse effects. Fractionated laser resurfacing has now nearly supplanted traditional full-field laser resurfacing, and safe treatment of rhytides on the thin skin of the eyelids is possible43. It has also led to the removal of periorbital lesions, such as syringomas, xanthelasma, milia, and seborrheic keratosis. Coarse wrinkles in the periorbital area show good improvement in the regions submitted to a double-pass and non-sequential fractional ultrapulsed CO2 light treatment (ActiveFX, Lumenis Corp, Israel) is considered an excellent treatment for photodamaged facial skin44. The author has also used the Deka SmartXide (Florence, Italy) and Syneron Candela’s CO2RE (Israel) with good effect in this area. However, these ablative treatments are accompanied by significant downtime along with risk of possible infection and some physicians prefer non-ablative fractionalised resurfacing as a treatment with a lower therapeutic and side-effect profile.




A variety of differing aesthetic treatments are available for non-surgical periorbital rejuvenation but one procedure or technique alone is usually insufficient. The most popular treatments presently are platelet rich plasma, HIFU devices (Ulthera), RF devices (BTL Exilis), and red light (Omnilux, GENO-LED).



Declaration of interest The authors report no conflicts of interest.

Figures 1  Adapted from reference 21, illustration © Kevin February; 2, 5, 6  © Patrick Treacy; 3 Illustration © Kevin February


  1. Moran ML. Office-based periorbital rejuvenation. Facial Plast Surg. 2013 Feb;29(1):58-63. doi: 10.1055/s-0033-1333834. Epub 2013 Feb 20
  2. Roberts 3rd TL. Laser blepharoplasty and laser resurfacing of the periorbital area. Clin Plast Surg. 1998; 25(1):95–108
  3. Combining therapies for the ageing face: The DUBLiN Lift Patrick Treacy / PRIME Aesthetic Journal October 10, 2012
  4. Frankel AS. Botox for rejuvenation of the periorbital region. Facial Plast Surg. 1999;15 (3):255-62
  5. Carruthers A, Caruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:325–53
  6. Guerrissi J, Sarkissian P. Local injection into mimetic muscles ofbotulinum toxin A for the treatment of facial lines. Ann Plast Surg 1997;39:447–53
  7. West TB, Alster TS. Effect of botulinum toxin type A on movement-associated rhytides following cutaneous CO2 laser resurfacing. Lasers Surg Med 1998; Suppl 10:7
  8. Tucker-Samaras S, Zedayko T, Cole C, Miller D, Wallo W, Leyden JJ. A stabilized 0.1% retinol facial moisturizer improves the appearance of photodamaged skin in an eight-week, double-blind, vehicle-controlled study. Drugs Dermatol. 2009 Oct;8(10):932-6
  9. Alster TS. Periorbital Rejuvenation: A Review of Dermatologic Treatments. Dermatol Surg 1999; 25:1
  10. Abdel Meguid AM, Elaziz Ahmed Attallah DA, Omar H. Trichloroacetic Acid Versus Salicylic Acid in the Treatment of Acne Vulgaris in Dark-Skinned Patients. Dermatol Surg 2015; 41(12): 1398-404
  11. Polder KD, Bruce S. Radiofrequency: thermage. Facial Plast Surg Clin North Am 2011;19 (2):347–59. Epub 2011/07/19
  12. Stampar M. The Pelleve procedure: an effective method for facial wrinkle reduction and skin tightening. Facial Plast Surg Clin North Am 2011; 19(2):335-45. doi: 10.1016/j.fsc.2011.05.012
  13. Alexiades-Armenakas M, Dover JS, Arndt KA. Unipolar versus bipolar radiofrequency treatment of rhytides and laxity using a mobile painless delivery method. Lasers Surg Med 2008;40(7): 446–53
  14. Gliklich RE, White WM, Slayton MH, Barthe PG, Makin IR. Clinical pilot study of intense ultrasound therapy to deep dermal facial skin and subcutaneous tissues. Arch Facial Plast Surg 2007;9 (2):88–95
  15. Nelson AA, Beynet D, Lask GP. A novel non-invasive radiofrequency dermal heating device for skin tightening of the face and neck. J Cosmet Laser Ther 2015; 3:1-6. [Epub ahead of print]
  16. Bloom BS, Emer J, Goldberg DJ. Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther. 2012; 14 (5):208-11. doi: 10.3109/14764172.2012.724534
  17. Fabi SG. Noninvasive skin tightening: focus on new ultrasound techniques. Clin Cosmet Investig Dermatol 2015; 8:47-52. doi: 10.2147/CCID.S69118. eCollection 2015
  18. Oni G, Hoxworth R, Teotia S, Brown S, Kenkel JM. Evaluation of a microfocused ultrasound system for improving skin laxity and tightening in the lower face. Aesthet Surg J 2014; 34 (7):1099-110. doi: 10.1177/1090820X14541956. Epub 2014 Jul 2
  19. Laubach HJ, Makin IR, Barthe PG, Slayton MH, Manstein D. Intense focused ultrasound: evaluation of a new treatment modality for precise microcoagulation within the skin. Dermatol Surg 2008; 34:727-34
  20. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dematol Clin 2005; 23: 343–63.
  21. Sharad J. Dermal Fillers for the Treatment of Tear Trough Deformity: A Review of Anatomy, Treatment Techniques, and their Outcomes. J Cutan Aesthet Surg 2012; 5(4): 229–238. doi:  10.4103/0974-2077.104910 PMCID: PMC3560162
  22. Bravo BS, Rocha CR, Bastos JT, Silva PM. Comprehensive Treatment of Periorbital Region with Hyaluronic Acid. J Clin Aesthet Dermatol 2015; 8(6):30-5
  23. Huber-Vorländer J, Kürten M. Correction of Tear Trough Deformity With a Cohesive Polydensified Matrix Hyaluronic Acid: A Case Series. Plast Surg Nurs 2015; 35(4): 171-6
  24. Raspaldo H: Volumizing effect of a new hyaluronic acid sub-dermal facial filler: a retrospective analysis based on 102 cases. J Cosmet Laser Ther 2008, 10:134-14
  25. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg.2004;6:234–39
  26. Busso M, Karlsberg PL. Cheek augmentation and rejuvenation using Radiesse. Cosmetic Dermatology 2006; 19:583–8
  27. Raivier MH, Bass LS, Busso M, Jasin ME, Narins RS, Tzikas TL. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg 2007; 120 (6 Suppl):55S-66S
  28. Glaser DA, Patel U. Enhancing the eyes: use of minimally invasive techniques for periorbital rejuvenation. J Drugs Dermatol 2010; 9(8 Suppl ODAC Conf Pt 2): s118-28
  29. Sadick NS, Bosniak SL, Cantisano-Zilkha M, Glavas IP, Roy D. Definition of the tear trough and the tear trough rating scale. J Cosmet Dermatol 2007; 6(4): 218-22
  30. Tear trough implants for correction of tear trough deformity. Flowers RS Clin Plast Surg. 1993; 20(2):403-15
  31. Sadick NS, Bosniak SL, Cantisano-Zilkha M, Glavas IP, Roy D. Definition of the tear trough and the tear trough rating scale. J Cosmet Dermatol 2007; 6(4): 218-22
  32. Leo MS, Kumar AS, Kirit R, Konathan R, Sivamani RK. Systematic review of the use of platelet-rich plasma in aesthetic dermatology. Cosmet Dermatol. 2015 Jul 23. doi: 10.1111/jocd.12167
  33. Eppley L, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery Plast Reconstr Surg 2006; 118
  34. Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg 2009; 25: 270–276
  35. Bhat J, Birch J, Whitehurst C and Lanigan SW. A Single-Blinded Randomized Controlled Study to Determine the Efficacy of Omnilux Revive Facial Treatment in Skin Rejuvenation. Lasers in Medical Science 2005; 20: 6-10
  36. Russell BA, Kellett N and Reilly LR. A study to determine the efficacy of combination LED light therapy (830 nm and 633 nm) in facial skin rejuvenation. Journal of Cosmetic and Laser Therapy 2005; 7
  37. Baez F and Reilly LR. The use of light-emitting diode therapy in the treatment of photoaged skin. Journal of Cosmetic Dermatology 2007; 6: 189-194
  38. Kim JW. Clinical trial of Non thermal 633nm Omnilux LED array for renewal of Photoaging: Clinical Surface Profilometric Results. Journal of the Korean society for Laser Medicine and Surgery 2005; 9: 1-6
  39. Fabbrocini G, De Vita V, Pastore F, et al. Collagen induction therapy for the treatment of upper lip wrinkles. J Dermatolog Treat 2012; 23 (2)
  40. Majid I. Microneedling therapy in atrophic facial scars: an objective assessment. J Cutan Aesthet Surg 2009; 2 (1): 26–30
  41. Doddaballapur S. Microneedling with dermaroller. J Cutan Aesthet 2009; 2(2): 110–111
  42. Aust MC, Knobloch K, Reimers K, Redeker J, Ipaktchi R, Altintas MA, Gohritz A, Schwaiger N, Vogt PM Percutaneous collagen induction therapy: an alternative treatment for burn scars. Burns  2010; 36(6): 836-43. doi: 10.1016/j.burns.2009.11.014. Epub 2010 Jan 13.
  43. Yates B, Que SK, D’Souza L, Suchecki J, Finch JJ. Laser treatment of periocular skin conditions. Clin Dermatol. 2015 Mar-Apr;33(2):197-206. doi: 10.1016/j.clindermatol.2014.10.011.
  44. Clementoni MT, Gilardino PA, Muti GF, Eretta D, Schianch R. Non sequential fractional ultrapulsed C02 resurfacing of photoaged skin Journal of Cosmetic and Laser Therapy 2007; 9(4): 218–2250


, , , , , ,

Patrick Treacy Dr

Medical Director, Ailesbury Clinics Ltd and Ailesbury Hair Clinics Ltd, Dublin, Cork, London and Middle East

More articles by Patrick Treacy




Send to a colleague

  • Your details

  • Your colleague's details

  • Leave a message?